Deutsche Bank lowered the firm’s price target on Definitive Healthcare to $9 from $14 and keeps a Hold rating on the shares post the Q3 report.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on DH:
- Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
- Definitive Healthcare trading resumes
- Definitive Healthcare trading halted, volatility trading pause
- Definitive Healthcare reports Q3 EPS 9c, consensus 6c
- Definitive Healthcare Announces Timing of Its Third Quarter 2023 Financial Results Conference Call and Webcast
